Clinical trial
Efficacy and Safety Study of Varying Doses of Lanreotide Autogel in Patients…
NCT00234572 · Ipsen, Industry · Completed
Key facts
| NCT number | NCT00234572 |
|---|---|
| Title | Efficacy and Safety Study of Varying Doses of Lanreotide Autogel in Patients With Acromegaly |
| Official title | Phase II, Multicentre, Randomized, Double-blind Study in Acromegalic Patients Evaluating the Efficacy and Safety of a Single Deep Subcutaneous Administration of Lanreotide Autogel (60, 90 or 120mg) Versus Placebo Followed by a Single Blind Fixed Dose Phase Evaluating the Pharmacokinetic… |
| Lead sponsor | Ipsen, Industry |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Acromegaly |
| Intervention type | Drug |
| Interventions | Lanreotide (Autogel formulation) |
| Enrollment | 108 |
| Start date | May 1, 2000 |
| Primary completion | Jan 3, 2003 |
| Completion | Jan 3, 2003 |
| First posted | Oct 7, 2005 |
| Last update posted | Aug 2, 2019 |
| Countries | Czechia, France, Germany, Hong Kong, Hungary, Netherlands, United Kingdom, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: